Utah Medical Products, Inc. (UTMD)
74.80
+0.31
(+0.42%)
USD |
NASDAQ |
Sep 29, 16:00
74.80
0.00 (0.00%)
After-Hours: 19:44
Utah Medical Products Enterprise Value : 149.77M for Sept. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 28, 2026 | 149.77M |
| September 25, 2026 | 148.78M |
| September 24, 2026 | 150.60M |
| September 23, 2026 | 151.42M |
| September 22, 2026 | 156.68M |
| September 21, 2026 | 149.74M |
| September 18, 2026 | 148.08M |
| September 17, 2026 | 148.81M |
| September 16, 2026 | 148.40M |
| September 15, 2026 | 150.21M |
| September 14, 2026 | 137.61M |
| September 11, 2026 | 134.55M |
| September 10, 2026 | 134.33M |
| September 09, 2026 | 134.59M |
| September 08, 2026 | 132.80M |
| September 04, 2026 | 138.98M |
| September 03, 2026 | 137.74M |
| September 02, 2026 | 140.70M |
| September 01, 2026 | 141.08M |
| August 31, 2026 | 139.07M |
| August 28, 2026 | 144.29M |
| August 27, 2026 | 141.21M |
| August 26, 2026 | 138.31M |
| August 25, 2026 | 138.53M |
| August 24, 2026 | 140.63M |
| Date | Value |
|---|---|
| August 21, 2026 | 140.41M |
| August 20, 2026 | 140.00M |
| August 19, 2026 | 142.22M |
| August 18, 2026 | 141.84M |
| August 17, 2026 | 136.15M |
| August 14, 2026 | 138.66M |
| August 13, 2026 | 142.16M |
| August 12, 2026 | 142.26M |
| August 11, 2026 | 141.65M |
| August 10, 2026 | 139.71M |
| August 07, 2026 | 138.12M |
| August 06, 2026 | 135.38M |
| August 05, 2026 | 139.33M |
| August 04, 2026 | 142.80M |
| August 03, 2026 | 144.23M |
| July 31, 2026 | 137.13M |
| July 30, 2026 | 134.11M |
| July 29, 2026 | 138.47M |
| July 28, 2026 | 138.53M |
| July 27, 2026 | 132.61M |
| July 24, 2026 | 126.37M |
| July 23, 2026 | 116.95M |
| July 22, 2026 | 132.90M |
| July 21, 2026 | 132.77M |
| July 20, 2026 | 133.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 202.39B |
| AngioDynamics, Inc. | 605.12M |
| Alphatec Holdings, Inc. | 2.043B |
| AtriCure, Inc. | 2.877B |
| Baxter International, Inc. | 18.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 2.686M |
| Revenue (Quarterly) | 8.529M |
| Total Expenses (Quarterly) | 5.843M |
| EPS Diluted (Quarterly) | 0.8436 |
| Gross Profit Margin (Quarterly) | 55.60% |
| Profit Margin (Quarterly) | 31.49% |
| Earnings Yield | 4.39% |
| Operating Earnings Yield | 4.38% |
| Normalized Earnings Yield | 4.447 |